Loading...
•
Dec 31, 2020
DuPont Q4 2020 Earnings Report
DuPont's Q4 2020 financial performance was reported, showcasing mixed results with sales up 1% and strategic portfolio moves.
Key Takeaways
DuPont reported Q4 2020 results with net sales of $5.3 billion, a 1% increase year-over-year. GAAP EPS from continuing operations was $0.37, and adjusted EPS was $0.95. The company highlighted strong performance in Electronics & Imaging and progress in cost savings, while also focusing on strategic priorities such as the separation of the Nutrition & Biosciences business.
GAAP EPS from continuing operations was $0.37; adjusted EPS was $0.95.
Net Sales reached $5.3 billion, up 1 percent; organic sales were flat compared to the previous year.
GAAP Income from continuing operations totaled $279 million, with an Operating EBITDA of $1.3 billion.
The company achieved ~$130 million in non-manufacturing costs savings during the quarter.
DuPont
DuPont
DuPont Revenue by Segment
DuPont Revenue by Geographic Location
Revenue by Segment
ElectronicsCo Revenue
CapyFin.comRevenue by Geographic Location
U.S. & Canada Revenue
CapyFin.comEMEA Revenue
CapyFin.comAsia Pacific Revenue
CapyFin.comLatin America Revenue
CapyFin.com Forward Guidance
DuPont anticipates net sales between $15.4 and $15.6 billion for 2021, representing an 8% increase at the mid-point compared to 2020. Operating EBITDA is projected to be between $3.83 and $3.93 billion, a 13% increase at the mid-point versus 2020. Adjusted EPS is expected to range from $3.30 to $3.45 per share, a 68% increase at the mid-point compared to 2020.
Positive Outlook
- Expect net sales between $15.4 and $15.6 billion for 2021, an 8% increase at the mid-point versus 2020 net sales of $14.3 billion
- Operating EBITDA between $3.83 and $3.93 billion, a 13% increase at the mid-point versus 2020 operating EBITDA of $3.4 billion.
- Full year adjusted EPS is in the range of $3.30 to $3.45 per share, an increase of 68% at the mid-point versus 2020 adjusted EPS of $2.01 per share
- Expect a strong first quarter of 2021 with net sales between $3.75 and $3.85 billion
- Adjusted EPS in the range of $0.75 to $0.77 per share for Q1 2021